Medicare Enrolled
Dr. Philip Dreisbach, M.D.
Hematology & Oncology · Rancho Mirage, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dreisbach from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dreisbach?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dreisbach
Dr. Philip Dreisbach is a hematology & oncology specialist in Rancho Mirage, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Dreisbach performed 126,796 Medicare services across 3,291 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dreisbach received a total of $19,918 from 98 pharmaceutical and/or device companies across 1085 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dreisbach is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 5% volume in CA
$19,918 industry payments
Medicare Practice Summary
Medicare Utilization ↗126,796
Medicare services
Top 5% in CA for hematology & oncology
3,291
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~6,673 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
60,000 | $1 | $3 |
| Denosumab injection (Prolia/Xgeva) | 24,000 | $18 | $59 |
| Pembrolizumab injection (Keytruda) | 11,700 | $43 | $137 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
7,680 | $6 | $21 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
5,960 | $36 | $119 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
5,700 | $0 | $1 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,347 | $0 | $0 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,295 | $8 | $25 |
| Injection, heparin sodium, (heparin lock flush), per 10 units | 1,100 | $0 | $0 |
| Injection, granisetron hydrochloride, 100 mcg | 1,050 | $0 | $1 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
859 | $8 | $18 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
652 | $12 | $37 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
636 | $10 | $55 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
584 | $148 | $470 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
540 | $88 | $842 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
523 | $13 | $45 |
| Anti-nausea injection (Aloxi/palonosetron) | 510 | $1 | $7 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
434 | $105 | $337 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
255 | $74 | $238 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
243 | $55 | $194 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
242 | $11 | $36 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
225 | $114 | $390 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
198 | $1 | $3 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
192 | $1 | $2 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
129 | $18 | $58 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
106 | $24 | $82 |
| New patient office visit, complex (60-74 min) | 82 | $178 | $573 |
| Bone density scan (DEXA) of hip, pelvis, and spine This test measures bone density in the hip, pelvis, and spine to assess bone strength. It also includes an assessment for spine fractures. |
77 | $56 | $141 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
69 | $79 | $286 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
65 | $99 | $292 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
51 | $29 | $88 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
47 | $56 | $189 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
46 | $25 | $84 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
38 | $6 | $15 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
37 | $1 | $7 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
35 | $62 | $238 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
27 | $1 | $20 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
24 | $2 | $10 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
16 | $28 | $95 |
| Stool test for hidden blood (FIT) A laboratory test that analyzes a stool sample to detect hidden blood using an immunoassay method. |
11 | $16 | $40 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
11 | $7 | $20 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
52.8% high complexity
43.5% medium
3.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$19,918
Total received (2018-2024)
Avg $2,845/year across 7 years
Top 21% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
98
Companies
1,085
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,613 (98.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$305 (1.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,421
2023
$3,441
2022
$3,042
2021
$2,806
2020
$2,410
2019
$2,376
2018
$2,422
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$260
Daiichi Sankyo Inc.
$252
AstraZeneca Pharmaceuticals LP
$214
Janssen Biotech, Inc.
$194
Novartis Pharmaceuticals Corporation
$186
Takeda Pharmaceuticals U.S.A., Inc.
$167
ABBVIE INC.
$166
BeiGene USA, Inc.
$163
E.R. Squibb & Sons, L.L.C.
$154
Merck Sharp & Dohme LLC
$130
Celgene Corporation
$118
Astellas Pharma US Inc
$117
Gilead Sciences, Inc.
$98
Eisai Inc.
$78
SOBI, INC
$75
Tempus AI, Inc
$73
Dendreon Pharmaceuticals LLC
$70
Regeneron Healthcare Solutions, Inc.
$69
GENZYME CORPORATION
$68
PUMA BIOTECHNOLOGY, INC.
$68
Ipsen Biopharmaceuticals, Inc
$67
Kite Pharma, Inc.
$63
Genentech USA, Inc.
$59
Deciphera Pharmaceuticals Inc.
$53
Incyte Corporation
$49
Stemline Therapeutics Inc.
$49
Alnylam Pharmaceuticals Inc.
$37
Rigel Pharmaceuticals, Inc.
$34
PharmaEssentia USA Corporation
$34
Genmab U.S., Inc.
$33
ARRAY BIOPHARMA INC
$28
Coherus Biosciences Inc.
$25
Boehringer Ingelheim Pharmaceuticals, Inc.
$25
SERVIER PHARMACEUTICALS LLC
$24
Bayer Healthcare Pharmaceuticals Inc.
$23
RECORDATI_RARE_DISEASES_INC.
$19
Kyowa Kirin, Inc.
$17
JAZZ PHARMACEUTICALS INC.
$16
TAIHO ONCOLOGY, INC.
$15
CSL Behring
$15
Lilly USA, LLC
$14
Top 3 companies account for 21.2% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,633
AstraZeneca Pharmaceuticals LP
$1,536
Janssen Biotech, Inc.
$1,076
E.R. Squibb & Sons, L.L.C.
$1,011
Amgen Inc.
$877
PFIZER INC.
$841
Daiichi Sankyo Inc.
$784
Astellas Pharma US Inc
$687
Regeneron Healthcare Solutions, Inc.
$578
BeiGene USA, Inc.
$494
Incyte Corporation
$491
Seagen Inc.
$462
Genentech USA, Inc.
$419
Celgene Corporation
$399
Gilead Sciences, Inc.
$396
Coherus Biosciences Inc.
$335
Takeda Pharmaceuticals U.S.A., Inc.
$315
Pharmacyclics LLC, An AbbVie Company
$312
GENZYME CORPORATION
$289
GlaxoSmithKline, LLC.
$287
Merck Sharp & Dohme Corporation
$285
Merck Sharp & Dohme LLC
$275
Puma Biotechnology, Inc.
$274
Rigel Pharmaceuticals, Inc.
$252
Foundation Medicine, Inc.
$235
ABBVIE INC.
$229
Dendreon Pharmaceuticals LLC
$221
Boehringer Ingelheim Pharmaceuticals, Inc.
$189
AbbVie Inc.
$187
Lilly USA, LLC
$187
Ipsen Biopharmaceuticals, Inc
$181
EMD Serono, Inc.
$166
EISAI INC.
$163
TerSera Therapeutics LLC
$163
Teva Pharmaceuticals USA, Inc.
$159
Eisai Inc.
$151
Bayer HealthCare Pharmaceuticals Inc.
$143
CSL Behring
$139
Pharmacyclics LLC, an AbbVie Company
$137
Deciphera Pharmaceuticals Inc.
$128
PUMA BIOTECHNOLOGY, INC.
$128
Seattle Genetics, Inc.
$125
Blueprint Medicines Corporation
$119
Kite Pharma, Inc.
$116
AVEO Pharmaceuticals, Inc.
$116
Karyopharm Therapeutics Inc.
$111
SOBI, INC
$97
ARRAY BIOPHARMA INC
$96
Octapharma USA, Inc.
$92
Tempus AI, Inc
$73
Spectrum Pharmaceuticals Inc.
$73
Stemline Therapeutics Inc.
$73
Alexion Pharmaceuticals, Inc.
$67
Heron Therapeutics, Inc.
$65
Alnylam Pharmaceuticals Inc.
$62
Exelixis Inc.
$58
Taiho Oncology, Inc.
$57
Dova Pharmaceuticals
$55
TOLMAR Pharmaceuticals, Inc.
$54
Bayer Healthcare Pharmaceuticals Inc.
$53
Adaptive Biotechnologies Corporation
$52
MorphoSys, US Inc.
$49
SERVIER PHARMACEUTICALS LLC
$48
Verity Pharmaceuticals Inc.
$48
Clovis Oncology, Inc.
$46
SANOFI-AVENTIS U.S. LLC
$44
Acceleron Pharma, Inc.
$44
GE HealthCare
$44
Mirati Therapeutics, Inc.
$42
AbbVie, Inc.
$41
Blue Earth Diagnostics Limited
$39
AMAG Pharmaceuticals, Inc.
$39
Secura Bio, Inc.
$39
Jazz Pharmaceuticals Inc.
$39
Sun Pharmaceutical Industries Inc.
$35
PharmaEssentia USA Corporation
$34
Epizyme, Inc.,
$34
Genmab U.S., Inc.
$33
JAZZ PHARMACEUTICALS INC.
$30
Kyowa Kirin, Inc.
$30
Helsinn Therapeutics (U.S.), Inc.
$25
TG THERAPEUTICS, INC.
$25
Agios Pharmaceuticals, Inc.
$24
Janssen Pharmaceuticals, Inc
$23
TESARO, Inc.
$23
Sobi, Inc
$22
Array BioPharma Inc.
$22
Pharmacosmos Therapeutics Inc.
$19
RECORDATI_RARE_DISEASES_INC.
$19
Partner Therapeutics, Inc.
$18
Sumitomo Pharma America, Inc.
$18
Shire North American Group Inc
$17
TAIHO ONCOLOGY, INC.
$15
Myriad Genetic Laboratories, Inc.
$15
Novocure Inc.
$14
ADC Therapeutics America, Inc.
$13
EUSA Pharma (US) LLC
$11
Aurobindo Pharma USA, Inc.
$11
Top 3 companies account for 21.3% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AKYNZEO · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Afstyla · Alecensa · Aliqopa · Avastin · Axumin · BALVERSA · BAVENCIO · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Beleodaq · Blincyto · Braftovi · CABLIVI · CALQUENCE · CARVYKTI · CHANTIX · CINVANTI · CUVITRU · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · EVENITY · Enhertu · Epkinly · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Farydak · Folotyn · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · Gazyva · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · Idelvion · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lonsurf · MAVYRET · MEKINIST · MONJUVI · MONOFERRIC · MYCHOICE CDX · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXLUMO · Onivyde · Optune · Orserdu · PADCEV · PIQRAY · PLUVICTO · POSLUMA · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Perjeta · Pomalyst · Poteligeo · QINLOCK · Quzyttir · REBLOZYL · ROLVEDON · RUXIENCE · RYBREVANT · RYDAPT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · SUSTOL · SUTENT · SYLVANT · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tecentriq · Tibsovo · Trelstar · Trodelvy · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · VPRIV · VYXEOS · Vectibix · Venclexta · Vitrakvi · Vyloy · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · XYNTHA · Xermelo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
17
Per 100K population
0.7
County median income
$89,672
Nearest hospital
EISENHOWER MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dreisbach is a mixed practice specialist, with above-average Medicare volume (top 5% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dreisbach experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Dreisbach performed 60,000 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dreisbach receive payments from pharmaceutical companies?
Yes. Dr. Dreisbach received a total of $19,918 from 98 companies across 1,085 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dreisbach's costs compare to other hematology & oncology specialists in Rancho Mirage?
Dr. Dreisbach's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dreisbach) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Rancho Mirage
Browse hematology & oncology specialists in Rancho Mirage ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology